参考文献/References:
[1] Guazzelli Marques C, de Piano Ganen A, Zaccaro de Barros A, et al. Weight loss probiotic supplementation effect in overweight and obesity subjects: A review. Clin Nutr, 2020, 39(3):694-704.
[2] Saklayen MG. The global epidemic of the metabolic syndrome.Curr Hypertens Rep, 2018, 20(2):12.
[3] Lu J, Wang L, Li M, et al. Metabolic syndrome among adults in China: the 2010 China noncommunicable disease surveillance. J Clin Endocr Metab, 2017, 102(2):507-515.
[4] 刘金钢 . 减重手术术式选择及对机体代谢的调节 . 肠外与肠内营养, 2020,27(1):1-4.
[5] Wan Y, Wang F, Yuan J, et al. Effects of dietary fat on gut microbiota and faecal metabolites，and their relationship with cardiometabolic risk factors: a 6-month randomised controlledfeeding trial. Gut, 2019, 68(8):1417-1429.
[6] 司原成, 苗维纳, 何嘉悦, 等 . 肥胖-肠道菌群-Toll样受体交互调控作用的研究进展 . 世界华人消化杂志, 2016, 24(15): 2361-2367.
[7] Valdes AM, Walter J, Segal E, et al. Role of the gut microbiota in nutrition and health. BMJ, 2018, 361, k2179.
[8] Lim MY, You HJ, Yoon HS, et al. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome. Gut,2017, 66(6):1031-1038.
[9] 王 洋, 周礼红 . 肥胖人群肠道菌群多样性研究 . 贵州大学学报(自然科学版), 2018, 35(04): 47-53.
[10] Breuninger TA, Wawro N, Breuninger J, et al. Associations between habitual diet, metabolic disease, and the gut microbiota using latent Dirichlet allocation. Microbiome, 2021, 9(1)：61.
[11] Zawada A, Rychter AM, Ratajczak AE, et al. Does gutmicrobiome interaction protect against obesity and obesityassociated metabolic disorders. Microorganisms, 2020, 9(1):18.
[12] Al Bander Z, Nitert MD, Mousa A, et al. The Gut Microbiota and Inflammation: An Overview. Int J Environ Res Public Health, 2020, 17(20): 7618.
[13] Si YC, Miao WN, He JY, et al. Regulating gut flora dysbiosis in obese mice by electroacupuncture. Am J Chin Med, 2018, 46(7):1-17.
[14] Zhi C, Huang J, Wang J, et al. Connection between gut microbiome and the development of obesity. Eur J Clin Microbiol Infect Dis, 2019, 38(11): 1987-1998.
[15] Czajkowska A, Ka?mierczak-Siedlecka K, Jamio?-Milc D, et al. Gut microbiota and its metabolic potential. Eur Rev Med Pharmacol Sci, 2020,24(24):12971-12977.
[16] 胡民万, 扈金萍 . 短链脂肪酸与代谢性疾病相关性的研究进展 . 国际药学研究杂志, 2020,47(11):881-886.
[17] 刘 倩, 陈 成, 辛 鑫, 等 . 短链脂肪酸对高脂饮食诱导肥胖小鼠糖脂代谢紊乱的影响 . 肝脏, 2018, 23(7):591-595.
[18] Natarajan N, Horid D, Flavahan S, et al. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. Physiol Genomics, 2016, 48 (11) :826-834.
[19] Karaki S, Tazoe H, Hayashi H, et al. Expression of the shortchain fatty acid receptor, GPR43, in the human colon. J Mol Histol, 2008, 39(2): 135-142.
[20] Amabebe E, Robert FO, Agbalalah T, et al. Microbial dysbiosisinduced obesity: role of gut microbiota in homeostasis of energy metabolism. Br J Nutr, 2020, 123(10):1127-1137.
[21] Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 2013, 504(7480):451-455.
[22] Ruting S, Xenaki D, Malouf M, et al. Short-chain fatty acids increase TNFα -induced inflammation in primary human lung mesenchymal cells through the activation of p38 MAPK . Am J PhysiolLung Cell Mol Physiol, 2019, 316(1) : L157-L174.
[23] Rodriguez J, Neyrinck AM, hang Z, et al. Metabolite profiling reveals the interaction of chitin-glucan with the gut microbiota. Gut Microbes, 2020, 12(1): 1810530.
[24] Vatanen T, Franzosa EA, Schwager R, et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature, 2018,562(7728):589-594.
[25] Fang WJ, Xue HL, Chen X, et al. Supplementation with sodium butyrate modulates the composition of the gut microbiota and ameliorates high-fat diet-induced obesity in mice. J Nutr, 2019,149(5):747-754.
[26] Kurta N, Tokashiki N, Fukushima K, et al. Short chain fatty acid butyrate uptake reduces expressions of prostanoid EP4 receptors and their mediation of cyclooxygenase-2 induction in HCA-7 human co-lon cancer cells. Eur J Pharmacol, 2019, 853: 308-315.
[27] Li X, Guo J, Ji K, et al. Bamboo shoot fiber prevents obesity in mice by modulating the gut microbiota. Sci rep, 2016, 6: 32953.
[28] Murugesan S, Nirmalkar K, Hoyo-vadillo C, et al. Gut microbiome production of short-chain fatty acids and obesity in children. Eur J Clin Microbiol Infect Dis, 2017,37(4):621-625.
[29] Dayib M, Larson J, Slavin J. Dietary fibers reduce obesity-related disorders mechanisms of action. Curr Opin Clin Nutr Metab Care, 2020, 23(6): 445-450.
[30] Kivimki M, Kuosma E, Ferrie JE, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health, 2017, 2(6):277-285.
[31] 司原成, 王晓芳, 汪弋力, 等 . 营养性肥胖之免疫机制研究进展 . 中国实验方剂学杂志, 2016, 22(9): 230-234.
[32] Aktar R, Parkar N, Stentz R, et al. Human resident gut microbe bacteroides thetaiotaomicron regulates colonic neuronal innervation and neurogenic function. Gut Microbes, 2020, 11(6):1745-1757.
[33] Christiansen CB, Nordskov MB, Svendsen B, et al. The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon. Am J Physiol Gastrointest Liver Physiol, 2018, 315(1): G53-G65.
[34] Leong KSW, Jayasinghe TN, Derraik JGB, et al. Protocol for the gut bugs trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents. BMJ open, 2019, 9(4):026174.
[35] Yaribeygi H, Farrokhi FR, Butler AE, et al. Insulin resistance: review of the underlying molecular mechanisms. J Cell Physiol,2019, 234(6):8152-8161.
[36] Larraufie P, Martin-Gallausiaux C, Lapaque N, et al. SCFAs strongly stimulate PYY production in human enteroendocrine cells. Sci Rep, 2018, 8(1):74.
[37] Jin X, Guan Y, Bai H, et al. Effects of sEA on slow transit constipation through the Microbiota-Gut-Brain axis in rats. Evid Based Complement Alternat Med, 2020, 2020: 8828846.
[38] Pascale A, Marchesi N, Govoni S, et al. The role of gut microbiota in obesity，diabetes mellitus，and effect of metformin: new insights into old diseases. Curr Opin Pharmacol, 2019, 49:1-5.
[39] Holmes ZC, Silverman JD, Dressman HK, et al. Short-chain fatty acid production by gut microbiota from children with obesity
differs according to prebiotic choice and bacterial community composition. MBio, 2020, 11(4): e914-e920.
[40] Cani PD, Van Hul M, Lefort C, et al. Microbial regulation of organismal energy homeostasis. Nat Met, 2019, 1(1):34-46.
[41] Blaak EE, Canfora EE, Theis S, et al. Short chain fatty acids in human gut and metabolic health. Benef Microbes, 2020, 11(5):
411-455.
[42] Martinez-Guryn K, Hubert N, Frazier K, et al. Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids. Cell Host Microbe, 2018, 23(4):458-469.
[43] Rosenbaum M, Knight R, Leibel RL. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab, 2015, 26(9): 493-501.
[44] Steinert RE, Beglinger C, Langhans W. Intestinal GLP-1 and satiation-from man to rodents and back. Int J Obes (Lond), 2015, 40(2):198-205.
[45] Duca FA, Yue TY. Fatty acid sensing in the gut and the hypothalamus: in vivo and in vitro perspectives. Mol Cell Endocrinol, 2014, 397(1-2): 23-33.
[46] Liu R, Hong J, Xu X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med, 2017, 23(7): 859-868.
[47] Thursby E, Juge N. Introduction to the human gut microbiota.Biochem J, 2017, 474(11): 1823-1836.
[48] 葛晓龙, 丁 超, 李 宁, 等 . 粪菌移植改善肥胖和糖尿病病人的研究进展 . 肠外与肠内营养, 2015, 22(6):370-373.
[49] Liu S, Li E, Sun Z, et al. Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder. Sci Rep, 2019, 9(1) : 287.
相似文献/References:
[1]王科皓.短链脂肪酸与克罗恩病的研究进展[J].肠外与肠内营养杂志,2019,(06):366.[doi:10.16151/j.1007-810x.2019.06.011]
WANG Ke-hao,ZHU Wei-ming.Advances in the role of short-chain fatty acids in Crohn's disease[J].PARENTERAL & ENTERAL NUTRITION,2019,(02):366.[doi:10.16151/j.1007-810x.2019.06.011]
[2]罗 绰,等.肠道菌群与结直肠癌研究进展[J].肠外与肠内营养杂志,2019,(06):377.[doi:10.16151/j.1007-810x.2019.06.013]
LUO Chuo,HUANG Ming-jun,WANG Yi-lin,et al.Advances in relation of intestinal flora and colorectal cancer[J].PARENTERAL & ENTERAL NUTRITION,2019,(02):377.[doi:10.16151/j.1007-810x.2019.06.013]
[3]尹天翊,郝占西,王国盼,等.益生元改善慢性代谢性疾病的研究进展[J].肠外与肠内营养杂志,2022,(04):237.[doi:10.16151/j.1007-810x.2022.04.008]
YIN Tian-yi,HAO Zhan-xi,WANG Guo-pan,et al.Research progress of prebiotics in improving chronic metabolic diseases[J].PARENTERAL & ENTERAL NUTRITION,2022,(02):237.[doi:10.16151/j.1007-810x.2022.04.008]
[4]吴冰悦,赵武杰,贾漪涛.后生元的临床应用价值及前景展望[J].肠外与肠内营养杂志,2022,(04):242.[doi:10.16151/j.1007-810x.2022.04.009]
WU Bing-yue,ZHAO Wu-jie,JIA Yi-tao.The clinical application value and prospect of postbiotics[J].PARENTERAL & ENTERAL NUTRITION,2022,(02):242.[doi:10.16151/j.1007-810x.2022.04.009]
[5]唐玉秀,韦 瑶,金 钧.肠-肺轴以及粪菌移植在脓毒症中的作用[J].肠外与肠内营养杂志,2023,(03):179.[doi:10.16151/j.1007-810x.2023.03.010]
TANG Yu-xiu,WEI Yao,JIN Jun.Function of gut-lung axis and fecal bacteria transplantation in sepsis[J].PARENTERAL & ENTERAL NUTRITION,2023,(02):179.[doi:10.16151/j.1007-810x.2023.03.010]
[6]石培洁,冯 健,胡 健,等.基于“肠-肌轴”的营养干预在 ICU 获得性衰弱治疗的研究进展[J].肠外与肠内营养杂志,2023,(04):249.[doi:DOI : 10.16151/j.1007-810x.2023.04.010]
SHI Pei-jie,FENG Jian,HU Jian,et al.Progress of nutritional interventions based on the "gut-muscle axis" inthe treatment of acquired weakness in the ICU[J].PARENTERAL & ENTERAL NUTRITION,2023,(02):249.[doi:DOI : 10.16151/j.1007-810x.2023.04.010]
[7]贾 茹,魏世杰,陈文华,等.艾司奥美拉唑对大鼠肠道菌群结构组成的影响[J].肠外与肠内营养杂志,2023,(06):375.[doi:DOI : 10.16151/j.1007-810x.2023.06.010]
JIA Ru,WEI Shi-jie,CHEN Wen-hua,et al.Effect of esomeprazole on intestinal microbiota structure and composition in rats[J].PARENTERAL & ENTERAL NUTRITION,2023,(02):375.[doi:DOI : 10.16151/j.1007-810x.2023.06.010]
[8]方 淼.膳食纤维之于肿瘤：诱发还是预防[J].肠外与肠内营养杂志,2019,(01):24.[doi:10.16151/j.1007-810x.2019.01.011]